Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Repligen and Pfizer initiate drug discovery collaboration

Jan. 30, 1997

FDA to review generic immunosuppressant

Jan. 27, 1997

Peptide Therapeutics and Medeva collaborate on vaccine development

Jan. 27, 1997

NIH offers licenses for conjugate vaccine

Jan. 23, 1997

Anti-CD11a MAb enters clinical trials for second indication

Jan. 22, 1997

Aquila adjuvant shows promise as component of malaria vaccine

Jan. 20, 1997

Anti-IL-2 monoclonal antibody described by Ajinomoto

Jan. 20, 1997

Obstacles to tolerance induction in the treatment of autoimmune disease

Jan. 17, 1997

Betafectin clinical update

Jan. 13, 1997

AutoImmune initiates clinical trials in transplant rejection

Jan. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...